{"product_id":"understanding-infant-colic-and-the-gut-bacteria-connection-a-complete-guide-to-probiotic-research-for-parents","title":"Understanding Infant Colic and the Gut Bacteria Connection: A Complete Guide to Probiotic Research for Parents","description":"\u003cp\u003eThis review article explores the growing scientific evidence that imbalances in the gut microbiome (the community of bacteria living in the digestive tract) play a major role in infant colic, a condition that affects 8–20% of babies and accounts for 10–20% of all pediatrician visits in the first four months of life. The authors examined multiple clinical trials testing different probiotic formulations, finding that certain strains—particularly \u003cem\u003eLactobacillus reuteri\u003c\/em\u003e DSM 17938 in breastfed infants—show meaningful benefits, while other strains show mixed or no results depending on the baby's feeding method. Colicky infants consistently show a gut bacteria pattern of increased Enterobacteria (including \u003cem\u003eEscherichia\u003c\/em\u003e, \u003cem\u003eShigella\u003c\/em\u003e, \u003cem\u003eKlebsiella\u003c\/em\u003e, and \u003cem\u003eEnterobacter\u003c\/em\u003e) and decreased protective bacteria such as Bifidobacteria and Lactobacilli. The review concludes that while no universal probiotic solution exists yet, the evidence points to strain-specific and condition-specific benefits that warrant further large-scale research.\u003c\/p\u003e\n\n\u003ch1\u003eUnderstanding Infant Colic and the Gut Bacteria Connection: A Complete Guide to Probiotic Research for Parents\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#what-is-colic\"\u003eWhat Is Infant Colic?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#why-research-matters\"\u003eWhy This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#study-methods\"\u003eHow This Review Was Conducted\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#microbiota-findings\"\u003eKey Findings: The Gut Microbiota Imbalance in Colicky Babies\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#mechanisms\"\u003eHow Gut Bacteria May Trigger Colic Symptoms\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#probiotic-trials\"\u003eProbiotic Treatments: What the Clinical Trials Show\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eClinical Implications for Families\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of the Research\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Parents\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eColicky infants have reduced gut microbiome diversity, fewer Bifidobacteria\/Lactobacilli, and more Enterobacteria compared to healthy infants.\u003c\/li\u003e\n\u003cli\u003eLactobacillus reuteri DSM 17938 reduced crying time in multiple small trials of breastfed colicky infants; the largest mixed trial found no overall benefit.\u003c\/li\u003e\n\u003cli\u003eProbiotic effects are strain-specific: Bifidobacterium lactis BB-12 prevented colic in formula-fed infants, while Lactobacillus rhamnosus GG showed no clear treatment benefit.\u003c\/li\u003e\n\u003cli\u003eAll probiotic products in the reviewed trials were well tolerated with no reported side effects; larger studies are still needed.\u003c\/li\u003e\n\u003cli\u003eColic naturally resolves by age 4 to 6 months, and any probiotic benefits typically appear after 7 to 21 days of daily use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"what-is-colic\"\u003eWhat Is Infant Colic?\u003c\/h2\u003e\n\n\u003cp\u003eInfant colic—also called excessive crying syndrome—is a behavioral syndrome in babies aged 1 to 5 months old. It involves long periods of inconsolable crying and fussing in otherwise healthy infants. The crying episodes happen without any obvious cause, which is precisely why they cause so much worry for parents and caregivers.\u003c\/p\u003e\n\n\u003cp\u003eThe condition was first formally defined in 1954 by Dr. Wessel as excessive crying or paroxystic irritability without an apparent cause, lasting more than three hours a day, occurring more than three days a week, for three consecutive weeks. These became known as the \"Wessel criteria.\" However, doctors later realized this definition had limitations. In daily practice, many infants show abnormal, unexplained crying that doesn't perfectly match these criteria, and the amount of crying reported can vary based on cultural environment and subjective assessment.\u003c\/p\u003e\n\n\u003cp\u003eBecause of these issues, the Wessel criteria were eventually abandoned. Today, the Rome Foundation—an international organization that defines functional gastrointestinal disorders (FGIDs)—has established a consensus definition of colic as: \u003cem\u003e\"Recurrent and prolonged periods of infant crying, fussing, or irritability reported by caregivers that occur without obvious cause and cannot be prevented or resolved by caregivers.\"\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eKey facts about infant colic include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIncidence:\u003c\/strong\u003e Affects between 8% and 20% of infants\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDoctor visits:\u003c\/strong\u003e Accounts for 10–20% of all pediatrician consultations in the first 4 months of life\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Crying bouts most often occur in the late afternoon or evening, starting suddenly and often high-pitched\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePhysical signs:\u003c\/strong\u003e Colicky infants are frequently unsettled, fussy, or irritable, and may show signs of pain such as drawing up their knees or arching their back\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNatural resolution:\u003c\/strong\u003e The condition is auto-limited and typically disappears after the fourth or fifth month of life\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe impact on parents cannot be overstated. Excessive crying leads to parental exhaustion and anxiety, with serious consequences including difficulty concentrating, loss of patience, feelings of incompetence, fear of harming the child, early cessation of breastfeeding, and reduced face-to-face interaction with their baby. This is why finding effective treatments is so important.\u003c\/p\u003e\n\n\u003ch2 id=\"why-research-matters\"\u003eWhy This Research Matters\u003c\/h2\u003e\n\n\u003cp\u003eBecause colic affects otherwise healthy infants without a specific identifiable cause, its underlying biology (physiopathology) has been debated for decades. The condition is classified as a Functional Gastrointestinal Disease (FGID)—meaning the symptoms are real and physical, but standard medical tests cannot find a structural or biochemical explanation.\u003c\/p\u003e\n\n\u003cp\u003eThe scientific community has suggested a wide range of possible causes, which researchers have organized into categories. Those related to the infant include immaturity of the intestinal tract and epithelial barrier, immature gastrointestinal function (including motility and bile acid mechanisms), microbial imbalance in the gut, accumulation of gas, spastic colon, alterations in gut hormones, and transient food intolerance or allergy. Those related to parent-infant interaction include the last stage of the developmental \"crying curve\" seen in healthy infants, insufficient parent-to-child interaction, family tensions, parental anxiety, first-born status, maternal smoking, and increasing maternal age.\u003c\/p\u003e\n\n\u003cp\u003eIn recent years, one area of research has risen to particular prominence: the role of the gut microbiota—the trillions of bacteria and other microorganisms that live in the digestive tract. Independent research groups have consistently correlated alterations in gut microflora with infant colic, and this evidence is growing stronger.\u003c\/p\u003e\n\n\u003ch2 id=\"study-methods\"\u003eHow This Review Was Conducted\u003c\/h2\u003e\n\n\u003cp\u003eThis article is a short review paper published in the \u003cem\u003eArchives of Clinical Microbiology\u003c\/em\u003e journal by researchers from AB-Biotics, S.A. in Barcelona, Spain, in collaboration with the Children's Gastroenterology Unit at Barcelona Children's Hospital Foundation. Rather than conducting a new clinical trial, the authors systematically reviewed and summarized recent published findings on two main topics:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003eThe scientific evidence describing specific alterations in the gut microbiota of colicky infants that could trigger or facilitate colic\u003c\/li\u003e\n  \u003cli\u003eThe clinical and mechanistic evidence for several probiotic formulations used to manage infant colic\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe review compiles data from omics studies (research using advanced technologies like microarrays and metagenomic analysis to study the full genetic material of gut bacteria), observational studies comparing colicky versus healthy infants, and 13 clinical trials testing different probiotic strains. The primary outcome examined across most trials was the reduction in daily crying time—considered the main measure of a baby's discomfort.\u003c\/p\u003e\n\n\u003ch2 id=\"microbiota-findings\"\u003eKey Findings: The Gut Microbiota Imbalance in Colicky Babies\u003c\/h2\u003e\n\n\u003cp\u003eEarly observations dating back to the initial studies in this field found that colicky infants had lower counts of intestinal lactobacilli and bifidobacteria compared to healthy infants. Since then, modern research has painted a clearer picture. The microbiota profile of colicky infants can now be characterized by several consistent alterations:\u003c\/p\u003e\n\n\u003ch3\u003e1. Reduced Overall Microbial Diversity\u003c\/h3\u003e\n\u003cp\u003eOmics studies conducted through different methods (including microarrays and metagenomic analysis) have reported that colicky infants have a reduction in overall microbiota diversity compared to healthy infants. A less diverse gut ecosystem is generally considered less resilient and more vulnerable to disturbance by opportunistic organisms.\u003c\/p\u003e\n\n\u003ch3\u003e2. Depletion of Protective Bacteria\u003c\/h3\u003e\n\u003cp\u003eColicky infants show reduced proportions of Bifidobacteria, Bacteroides, and lactobacilli compared to healthy controls. These bacterial groups are generally associated with health benefits, including immune modulation and anti-inflammatory effects.\u003c\/p\u003e\n\n\u003ch3\u003e3. Overgrowth of Potentially Harmful Bacteria\u003c\/h3\u003e\n\u003cp\u003eConversely, colicky infants have increased proportions of Clostridium, Staphylococcus, and particularly Enterobacteria—a family that includes Escherichia, Shigella, Klebsiella, and Enterobacter species. These bacteria are opportunistic and commensal (normally present in small numbers), but their relative abundance appears to increase significantly in infant colic.\u003c\/p\u003e\n\n\u003cp\u003eThe table below summarizes these documented alterations and what they may mean for colicky infants:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLow microbiota diversity and stability:\u003c\/strong\u003e Leads to changes in the metabolome (the collection of by-products produced by gut bacteria), which can alter intestinal transit, cause spasmodic bowel movements, and result in higher levels of calprotectin—a known biomarker of gut inflammation\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIncreased Enterobacteriaceae:\u003c\/strong\u003e Causes gas accumulation leading to bloating and digestive discomfort, and triggers a pro-inflammatory and pain-sensitizing (hyperalgesia) reaction to lipopolysaccharides (endotoxins)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDecreased Bifidobacterium:\u003c\/strong\u003e Results in reduced immune response modulation and less protection for the infant gut\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDecreased Lactobacillus:\u003c\/strong\u003e Reduces the expression of anti-inflammatory genes that help improve gut function, motility, and reduce visceral pain\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"mechanisms\"\u003eHow Gut Bacteria May Trigger Colic Symptoms\u003c\/h2\u003e\n\n\u003cp\u003eThe authors explain several biological mechanisms by which these bacterial changes may translate into the distressing symptoms of colic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGas production and digestive discomfort.\u003c\/strong\u003e Enterobacterial species are known to produce gas as a result of their metabolism. A higher relative abundance of these bacteria could therefore facilitate bloating and digestive discomfort in colicky babies. Changes in the bacterial metabolome can also slow intestinal transit, allowing gas to accumulate further and worsening the discomfort.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eInflammation and pain sensitivity (allodynia).\u003c\/strong\u003e A particularly important mechanism involves lipopolysaccharide (LPS) molecules—also known as endotoxins—which are components of the outer membrane of certain bacteria. The LPS from Enterobacteria is especially pro-inflammatory compared to LPS from other common gut Gram-negative bacteria such as Bacteroides. This inflammatory effect is mediated by Toll-like receptors (proteins on immune cells that recognize bacterial components), and is known to reduce visceral sensory and pain thresholds—a phenomenon called allodynia—both in animal models and in humans. Through this mechanism, a higher relative abundance of Enterobacteria could trigger a state of low-grade inflammation and increased visceral sensitivity in colicky infants, making normal digestive processes feel painful.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe protective role of Bifidobacteria and Lactobacilli.\u003c\/strong\u003e The evidence suggests that a high proportion of Bifidobacterium and Lactobacillus in an infant's microbiota is protective against colicky crying and fussing. This protective effect may be related to the fact that mucosal Lactobacillus species can induce the expression of anti-inflammatory genes, improving gut function and motility while reducing visceral pain. In addition, both lactobacilli and bifidobacteria may protect against colic by modulating the immune response.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy colic resolves on its own around 4–6 months.\u003c\/strong\u003e The authors point out that certain age-related changes in the intestinal environment help explain the natural resolution of colic. First, bile acids—a key environmental factor that shapes gut bacteria at high taxonomic levels—undergo significant changes during the first months of life. The ratio of cholic acid to chenodeoxycholic acids in the duodenum, as well as bile acid levels in the serum, are both increased during this period. Second, the overall diversity of the intestinal microbiome increases with age during the first months of life. Increased diversity is known to make ecosystems more resistant to disruption by opportunistic organisms, such as the Enterobacteria that overgrow in colicky infants.\u003c\/p\u003e\n\n\u003ch2 id=\"probiotic-trials\"\u003eProbiotic Treatments: What the Clinical Trials Show\u003c\/h2\u003e\n\n\u003cp\u003eBecause the evidence linking gut microbiota imbalances to infant colic is so compelling, many clinical trials have explored whether supplementing colicky infants with probiotics—beneficial live bacteria—can relieve symptoms. Since no effective conventional solution for excessive crying exists, probiotics represent an important area of investigation. All studies reported good tolerability and an absence of side effects. The results, however, are highly strain-specific and depend on whether the infant is breastfed or formula-fed. Here is what the research found for each formulation studied:\u003c\/p\u003e\n\n\u003ch3\u003eBifidobacterium lactis BB-12 + Streptococcus thermophilus\u003c\/h3\u003e\n\u003cp\u003eIn one of the earliest studies, Saavedra and colleagues (2004) conducted a randomized, double-blind, placebo-controlled prophylactic (preventive) trial in 180 healthy infants aged 3 to 24 months. A standard milk-based formula containing Bifidobacterium lactis BB-12 and an unspecified strain of Streptococcus thermophilus was given to the treatment group. The results showed a significantly lower reported incidence of colic in the probiotic group compared to controls. This was one of the first proofs that Bifidobacteria could play an important role in preventing infant colic. However, no therapeutic studies have assessed this combination as a treatment for colic after the inconsolable crying has already begun.\u003c\/p\u003e\n\n\u003ch3\u003eLactobacillus reuteri DSM 17938\u003c\/h3\u003e\n\u003cp\u003eLactobacillus reuteri DSM 17938 is one of the most studied probiotic strains for treating infant colic. Several small studies in predominantly breastfed colicky infants have consistently reported significant benefits:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSavino et al. (2010):\u003c\/strong\u003e A randomized, double-blind, placebo-controlled study in 46 breastfed infants found a significant reduction in crying time in the probiotic group after 21 days. The responder rate (defined as a 50% reduction in crying time) was significantly higher in the L. reuteri group. Fecal analysis showed a significant increase in lactobacilli and a reduction in Escherichia coli and ammonia in the treatment group.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSzajewska et al. (2013):\u003c\/strong\u003e This study enrolled 80 breastfed infants and found a significantly higher responder rate in the probiotic group on days 7, 14, 21, and 28. Crying time was significantly reduced, with improvement apparent as early as day 7. Parental perception of colic severity and family quality of life also improved significantly by day 7.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRoos et al. (2013):\u003c\/strong\u003e A smaller study of 29 breastfed infants found a significantly higher responder rate in the probiotic group, but also noted very high inter-individual variability. Microbiota analysis showed an increase in Bacteroidetes and the genus Bacteroides in responders between day 21 and day 0.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMi et al. (2015):\u003c\/strong\u003e In an observational randomized, placebo-controlled study of 42 breastfed infants, the probiotic group achieved a strikingly higher responder rate—100% versus only 15.7% in the placebo group. Significant differences in crying time appeared as early as day 7 and were even greater after 4 weeks. Parent satisfaction and maternal depression scores improved significantly in the probiotic group from the first week.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChau et al. (2015):\u003c\/strong\u003e A double-blind, placebo-controlled trial in 52 breastfed infants found significantly shorter crying time and a significantly higher responder rate at day 21 in the probiotic group.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eAccording to meta-analysis, the effects of L. reuteri were most evident after 21 days of supplementation. However, one major trial found conflicting results:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSung et al. (2014):\u003c\/strong\u003e This randomized, double-blind, placebo-controlled study of 167 infants—including both breastfed and formula-fed babies—found no significant difference in responder rate in the overall population (P=0.23). Unexpectedly, the placebo group had a significantly higher reduction in crying time, particularly with respect to fussing in formula-fed infants (79 minutes on average, P=0.005). Additionally, infants in the probiotic group slept significantly less (P=0.04). No significant differences were found in maternal mental health, family functioning, parent quality of life (though both groups improved at 6 months), fecal microbiota diversity, or colonization with E. coli.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFollowing these results, the latest World Gastroenterology Organization (WGO) guidelines indicate that L. reuteri DSM 17938 \u003cem\u003emay\u003c\/em\u003e be effective for breastfed infants with colic, but it cannot currently be recommended for treating infantile colic in formula-fed infants, nor can it be routinely used to prevent infantile colic.\u003c\/p\u003e\n\n\u003ch3\u003eLactobacillus rhamnosus GG (LGG)\u003c\/h3\u003e\n\u003cp\u003eDespite being strongly supported for treating acute diarrhea in children, Lactobacillus rhamnosus GG has not achieved positive results for baby colic in clinical trials:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePärtty et al. (2015):\u003c\/strong\u003e In a randomized, double-blind, placebo-controlled study of 30 breastfed and formula-fed infants, diary-verified crying time showed no statistical difference with LGG supplementation, although parental subjective assessment of daily crying suggested some effectiveness. The probiotic group did have a lower number of crying days and a higher rate of responders. Interestingly, this study replicated the finding that Bifidobacteria relative abundance was higher in healthy controls than in colicky infants. No significant changes were seen in fecal calprotectin or overall microbiota composition, though some Bifidobacterium species increased.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFatheree et al. (2016):\u003c\/strong\u003e A pilot study of 20 formula-fed infants found no differences in crying time, microbiota diversity, or genus-level composition when LGG-supplemented formula was compared to control formula. A significant increase in L. rhamnosus was confirmed, but no significant differences were seen in fecal calprotectin, cytokine levels, or regulatory T cell levels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThese results reinforce the growing evidence that probiotic effects are strain-specific and condition-specific, as the WGO guidelines suggest.\u003c\/p\u003e\n\n\u003ch3\u003eBifidobacterium breve BR03 + Bifidobacterium breve B632\u003c\/h3\u003e\n\u003cp\u003eGiglione and colleagues (2016) tested a combination of two Bifidobacteria strains in a randomized, double-blind, placebo-controlled prophylactic study of 60 breastfed and formula-fed infants. While no significant effects were observed in the full study population, there was a significant reduction in crying time in the formula-fed subgroup after 3 months of treatment compared to placebo. As with the earlier B. lactis BB-12 study, these results support the preventive use of these specific strains against infant colic in formula-fed infants, but are not sufficient to confirm their effectiveness as a treatment once colic has developed.\u003c\/p\u003e\n\n\u003ch3\u003ePediococcus pentosaceus CECT 8330 + Bifidobacterium longum CECT 7894\u003c\/h3\u003e\n\u003cp\u003ePediococci are round-shaped bacteria belonging to the Lactobacillus group. Santas and colleagues (2015) conducted a pilot randomized, double-blind, placebo-controlled trial of 20 breastfed and formula-fed colicky infants using a probiotic formula containing Pediococcus pentosaceus CECT 8330 and Bifidobacterium longum CECT 7894. The results showed a trend towards a greater reduction in daily crying time in the probiotic group compared to placebo after just 14 days (p=0.083)—a borderline result that suggests a promising effect. In vitro data suggest the mechanism of action involves an antagonistic effect against Enterobacteria and a capacity to counteract the pro-inflammatory effect of their endotoxins on immune cells.\u003c\/p\u003e\n\n\u003cp\u003eA follow-up study by Tintore and colleagues (2017) in 10 breastfed and formula-fed infants reported increases in overall microbiota diversity in the probiotic group, which was inversely correlated with crying time across the whole study population. The probiotic also produced a significant increase in the relative abundance of Bifidobacterium and a reduction in Enterobacteriaceae (mostly Escherichia\/Shigella) and Staphylococcus compared to placebo. These findings align with the observed relationship between infant colic, reduced microbiome diversity, and increased Enterobacterial abundance, and support the need for larger clinical studies to validate the earlier pilot results.\u003c\/p\u003e\n\n\u003ch3\u003eSimbiotic Formulas (Probiotics + Prebiotics)\u003c\/h3\u003e\n\u003cp\u003eKianifar and colleagues (2014) tested a mixture containing fructooligosaccharides (FOS—a type of prebiotic fiber) combined with seven unspecified probiotic strains of the species Lactobacillus casei, L. rhamnosus, L. bulgaricus, Streptococcus thermophilus, Bifidobacterium breve, and B. infantis. In a randomized, double-blind, placebo-controlled study of 45 breastfed infants, the probiotic group showed significantly higher responder rates and significant crying time reduction at days 7 and 30, and significantly better symptom resolution at day 7. However, the positive effect versus placebo had disappeared by day 30. No significant changes in weight gain were observed. Notably, because the individual probiotic strains were not specified, this limits the ability to replicate the study.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eClinical Implications for Families\u003c\/h2\u003e\n\n\u003cp\u003eThe take-home message from this body of research is that \u003cstrong\u003enot all probiotics are the same\u003c\/strong\u003e, and their effectiveness depends heavily on the specific strain and the infant's feeding method. For breastfed infants, Lactobacillus reuteri DSM 17938 has the strongest supportive evidence, with multiple small studies showing clinically meaningful reductions in crying time, and current WGO guidelines endorsing it as a possible treatment option. However, the largest trial did not confirm these benefits across a mixed population, and it actually suggested potential worsening in formula-fed infants.\u003c\/p\u003e\n\n\u003cp\u003eFor formula-fed infants, several Bifidobacterium-based products have shown preventive benefits, and the newest combination of Pediococcus pentosaceus CECT 8330 with Bifidobacterium longum CECT 7894 shows preliminary promise as a treatment. Still, these findings require validation in larger sample sizes before they can be routinely recommended.\u003c\/p\u003e\n\n\u003cp\u003eThe findings also emphasize that gut microbiota development is dynamic in early life. The fact that bacterial diversity naturally increases during the first months of life, combined with shifting bile acid profiles, likely explains why colic typically resolves on its own around 4 to 6 months of age regardless of treatment.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of the Research\u003c\/h2\u003e\n\n\u003cp\u003eParents should understand the limitations of the current evidence. Most of the positive clinical trials for L. reuteri involved small numbers of patients (ranging from 29 to 80 infants), which makes the results more vulnerable to statistical variability. Several were conducted in predominantly breastfed populations, so their findings cannot necessarily be generalized to formula-fed infants—indeed, the one large mixed study suggested possible harm in formula-fed babies. The promising results for Pediococcus pentosaceus + Bifidobacterium longum come from pilot studies with very small sample sizes (10–20 infants). The symbiotic formula study was hindered by its failure to specify the individual probiotic strains, making independent replication impossible. Many studies also relied on parental reports of crying time as the primary outcome, which is subject to subjectivity and cultural influences.\u003c\/p\u003e\n\n\u003cp\u003eThe authors note that further evidence is needed regarding validated mechanisms of action, and that randomized clinical studies with larger sample sizes are essential to confirm the benefits of probiotic approaches for infant colic. They also emphasize that the conflicting results between trials for the same strain (e.g., L. reuteri) remain unresolved.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Parents\u003c\/h2\u003e\n\n\u003cp\u003eBased on this review, here is what parents should keep in mind when navigating the confusing world of colic treatments and probiotics:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTalk to your pediatrician first.\u003c\/strong\u003e Infant colic is a diagnosis of exclusion—the crying must not have an identifiable medical cause. A healthcare professional should always evaluate your baby to rule out conditions such as reflux, food allergies, infections, or other problems that require medical treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk specifically about L. reuteri DSM 17938 if your baby is breastfed.\u003c\/strong\u003e The strongest evidence for probiotic treatment of colic in breastfed infants exists for this strain, with several randomized controlled trials showing reduced crying time and improved family quality of life. Note that the World Gastroenterology Organization considers it \"may be effective\" rather than a definitive recommendation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBe cautious with probiotics for formula-fed infants.\u003c\/strong\u003e The largest trial of L. reuteri actually found increased crying and fussing in formula-fed babies receiving the probiotic. Some Bifidobacterium-only products showed preventive benefits in formula-fed infants, but none are yet established as treatments for existing colic.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnow that effects take time.\u003c\/strong\u003e In the positive trials, meaningful improvements in crying time typically appeared after 7 to 21 days of daily probiotic use. Do not expect overnight results, and give any trial a reasonable duration before judging its effectiveness.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRemember that colic resolves on its own.\u003c\/strong\u003e The natural history of infant colic is spontaneous resolution by age 4 to 6 months. While probiotics may help ease symptoms in the interim, no treatment should introduce additional risk or stress. All the probiotic products studied were well tolerated with no reported side effects.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLook for strain-specific products.\u003c\/strong\u003e Review the label carefully. Probiotic effects are strain-specific—products listing \"Lactobacillus\" or \"Bifidobacterium\" without specific strain designations (such as DSM 17938 or CECT 7894) have not been studied for colic and are unlikely to have the same evidence base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsider the whole picture.\u003c\/strong\u003e Colic takes a heavy toll on parental mental health, and the research shows that family quality of life often improves when interventions reduce crying—even modestly. Seek support, share the burden of soothing duties, and discuss feelings of frustration or anxiety with your healthcare provider or support networks.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eIn conclusion, this review underscores that infant colic is a genuine medical condition with a complex—but increasingly understood—biological basis involving the gut microbiome. While the perfect probiotic solution has not yet been identified, the scientific journey has produced actionable insights for breastfeeding families and a clear roadmap for future research. Parents should feel empowered to discuss these findings with their pediatrician and make evidence-informed decisions for their families.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eCan probiotics help treat infant colic?\u003c\/h3\u003e\n\u003cp\u003eCertain probiotic strains show benefits, but effects are strain-specific and depend on feeding method. Lactobacillus reuteri DSM 17938 has the strongest evidence for reducing crying in breastfed infants. Other strains, such as Bifidobacterium lactis BB-12, showed preventive benefits in formula-fed infants, while some probiotics, like Lactobacillus rhamnosus GG, did not show clear treatment benefits.\u003c\/p\u003e\n\u003ch3\u003eIs Lactobacillus reuteri DSM 17938 effective for all babies with colic?\u003c\/h3\u003e\n\u003cp\u003eNo. Multiple small studies found L. reuteri DSM 17938 significantly reduced crying in breastfed infants. However, the largest trial, which included both breastfed and formula-fed babies, found no overall benefit and suggested possible worsening of fussing in formula-fed infants. Therefore, current guidelines say it may be effective for breastfed infants but cannot be recommended for formula-fed infants or for prevention.\u003c\/p\u003e\n\u003ch3\u003eAre probiotics safe for infants with colic?\u003c\/h3\u003e\n\u003cp\u003eAll probiotic products studied in the clinical trials reviewed were well tolerated, with no reported side effects. However, the trials varied in size and duration, and the authors note that larger studies are needed to confirm safety and effectiveness. Always talk to your pediatrician before giving your baby any supplement.\u003c\/p\u003e\n\u003ch3\u003eHow long does it take for probiotics to work for infant colic?\u003c\/h3\u003e\n\u003cp\u003eIn the positive clinical trials, meaningful improvements in crying time typically appeared after 7 to 21 days of daily probiotic use. For example, studies of L. reuteri showed significant reductions as early as day 7, with strongest effects after 21 days. Parents should not expect overnight results and should give a reasonable trial duration.\u003c\/p\u003e\n\u003ch3\u003eWhen does infant colic resolve on its own?\u003c\/h3\u003e\n\u003cp\u003eInfant colic is auto-limited and typically disappears after the fourth or fifth month of life, usually resolving by age 4 to 6 months. The natural increase in gut microbial diversity and changes in bile acids during early life may explain why colic resolves regardless of treatment.\u003c\/p\u003e\n\u003ch3\u003eWhen should I seek a second opinion about using probiotics to treat my baby's colic?\u003c\/h3\u003e\n\u003cp\u003eSeek a second opinion if your baby’s diagnosis is uncertain, because colic is a diagnosis of exclusion that requires ruling out reflux, food allergies, or infections. Also consider one before starting probiotics, especially for formula-fed infants: the largest L. reuteri trial found increased crying in this group, and no probiotic is established as a treatment for formula-fed colic. For breastfed infants, L. reuteri DSM 17938 has the strongest evidence but is still considered 'may be effective' by current guidelines. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal Article Title:\u003c\/strong\u003e ARCHIVES OF CLINICAL MICROBIOLOGY\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e \u003ca href=\"https:\/\/doi.org\/10.4172\/1989-8436.100056\" target=\"_blank\" rel=\"noopener\"\u003e10.4172\/1989-8436.100056\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Tintore M, Colome G, Santas J, and Espadaler J\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e Archives of Clinical Microbiology, Volume 8, No. 4:56, published August 10, 2017\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAffiliations:\u003c\/strong\u003e AB-Biotics, S.A., ESADE Creapolis, Sant Cugat del Vallès, Barcelona, Spain; Children's Gastroenterology Unit, Barcelona Children's Hospital Foundation, Barcelona, Spain\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e 10.4172\/1989-8436.100056\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle Type:\u003c\/strong\u003e Research Review\u003c\/p\u003e\n\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research. It is intended for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding your infant's health and before starting any supplement or treatment.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47483202633884,"sku":null,"price":0.0,"currency_code":"KRW","in_stock":true}],"url":"https:\/\/diagnosticdetectives.kr\/products\/understanding-infant-colic-and-the-gut-bacteria-connection-a-complete-guide-to-probiotic-research-for-parents","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}